Skip to main content

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

September 17, 2025

HMP · Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Greg Mattingly, MD examines safer alternatives and their limitations.

Related Content

Patient Case Studies: Successful Deprescription of Anticholinergics
What’s the Role of Amantadine in Anticholinergic Deprescription?
Case Managers, Telepsychiatry Offer Consistency in Schizophrenia Treatment
Treatment Options and Managing Side Effects in Schizophrenia
Can Anticholinergic Medications Make Movement Disorders Worse?
How to Taper Anticholinergic Medications Safely
Understanding the Cholinergic System
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy